Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells. by Messmann, H. et al.
British Joumal ofCancer(1997) 76(7), 878-883
© 1997 Cancer Research Campaign
Influence of a haematoporphyrin derivative on the
protoporphyrin IX synthesis and photodynamic effect
after 5-aminolaevulinic acid sensitization in human
colon carcinoma cells
H Messmann', M Geisler1, U GroB2, C Abels3, R-M Szeimies3, P Steinbach4, R Knuchel4, M Doss2,
J Scholmerich1 and A Holstege1
Department of 'Internal Medicine 1, University of Regensburg; 2Division of Clinical Biochemistry, Marburg; Departments of 3Dermatology and
4Pathology, University of Regensburg, Regensburg, Germany
Summary Haematoporphyrin derivatives (HPDs) are potent sensitizers in photodynamic therapy (PDT), associated with prolonged skin
photosensitivity. 5-Aminolaevulinic acid (5-ALA), a natural precusor of haem, is converted intracellularly into the photosensitive agent
protoporphyrin IX (PPIX), causing direct cytotoxicity after laser light irradiation but limited skin photosensitivity over 1-2 days and higher
tumour selectivity. Unfortunately, the use of 5-ALA in PDT has been shown to cause only superficial tissue necrosis. Therefore, a combination
of HPD and 5-ALA could be of great clinical value in the treatment of tumours if a synergistic effect of both sensitizers on tumour cell necrosis
with less skin photosensitivity could be demonstrated. Human colon adenocarcinoma cells (HT-29) were cultured with either HPD or 5-ALA
alone, simultaneously for 24 h with 5-ALA and HPD or in succession with 5-ALA (18 h) followed by HPD (6 h at different concentrations.
Intracellular PPIX concentrations were determined by high-performance thin-layerchromatography. Furthermore, PDTwas performed with an
incoherent light source (X = 580-740 nm) using a light dose of 30 J cm-2 and an output power of 40 mW cm-2. The intracellular PPIX
concentration correlated well with 5-ALA drug dose and incubation time and was highest after single 5-ALA sensitization. In the presence of
HPD, either simultaneously or sequentially, PPIX decreased significantly. The PDT effect after simultaneous incubation with both sensitizers
for24 h was not superior to incubation with HPD alone. If 5-ALA incubation (18 h) was followed by HPD (6 h) cytotoxicity after PDT was higher
than with either single drug. 5-ALA (80 gg ml-') led to a decrease in tumour cell viability by 40%. A similar effect could be observed when 5-
ALA and HPD were sequentially combined allowing for a reduction of the 5-ALA dose from 80gg ml-1 in the absence of HPD to 60 9g ml-' and
5,g ml-' together with 0.5,g ml-' and 2,g ml-' HPD respectively. We speculate that the enhanced PDT effect after the combined
administration of 5-ALA and HPD to cultures of colon carcinoma cells should be even more impressive in the tumour in vivo, since HPD
primarily targets the tumour microvasculature and secondarily tumour cells.
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Photodynamic therapy (PDT) is a promising non-thermal tech-
nique for inducing selective necrosis in neoplastic tissues with
laser light after prior administration of a photosensitizing drug.
The drug is activated by light of a specific wavelength matching
its absorption spectrum. In the presence of oxygen, the activated
sensitizer induces the formation of reactive oxygen species, in
particular singlet oxygen (Weishaupt et al, 1976). The ideal
photosensitizer accumulates almost exclusively in tumours with
minimal retention in the surrounding normal tissue.
The currently clinically approved photosensitizers [haematopor-
phyrin derivative (HPD) and its purified components] are powerful
sensitizers but with low tumour selectivity and prolonged skin
photosensitivity (Dougherty et al, 1990). In addition to tumour
cell-directed necrosis induced by PDT, HPD additionally accumu-
lates in endothelial cells (Leunig et al, 1994), allowing destruction
ofthe tumour vascular system (van Geel et al, 1994).
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5-Aminolaevulinic acid (5-ALA) is not a sensitizer by itselfbut
represents a naturally occurring precursor for the haem biosyn-
thetic pathway and has been used as a photosensitizing prodrug
that is metabolized intracellularly to porphyrins, known to be
efficient photosensitizers (Kennedy et al, 1990). 5-ALA has
several advantages when compared with other sensitizers in PDT:
5-ALA-induced porphyrins are rapidly eliminated from the body,
limiting skin sensitivity to 1-2 days (Regula et al, 1995). In addi-
tion, 5-ALA shows a better uptake and metabolism by tumour
cells than by their parent cells. The drug is effective in PDT
within the gastrointestinal tract (Gossner et al, 1995; Regula et al,
1995). Unfortunately, PDT induces only superficial tumour
necrosis in patients sensitized with 5-ALA (Regula et al, 1995).
Accordingly, several approaches have been made to improve the
PDT effect of5-ALA. Laserlight fractionation enhances the effect
of PDT after 5-ALA sensitization (Messmann et al, 1995).
Furthermore, the PDT effect after 5-ALA sensitization is wave-
length dependent, and best results can be achieved by
irradiating at 635 nm (Szeimies et al, 1995). The combination
of 5-ALA with desferrioxamine, an enzyme inhibitor of
ferrochelatase, increased the concentration of PPIX in normal
mucosa of the urinary bladder (Chang et al, 1994). This approach
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also led to a better PDT effect upon gastric and colonic carcinoma
cells (Tan et al, 1994).
The combination oftwo differentially acting sensitizers, such as
5-ALA and HPD, couldbe anotherpromising approach to enhance
PDT efficacy. Owing to its mechanism, 5-ALA is intracellularly
converted into PPIX and therefore induces direct phototoxicity
after PDT. In contrast, HPD is mainly targeted at tumour vessels
by accumulating in vascular endothelial cells enabling indirect
tumour destruction (Leunig et al, 1994). We wanted to clarify the
influence ofa haematoporphyrin derivative on the PP IX synthesis
after 5-ALA sensitization and whetherthe PDTeffect after5-ALA
sensitization can be enhanced by its combination with low-dose
HPD in vitro experiments using cultured human colonic adeno-
carcinoma cells.
If successful, additional administration of low-dose HPD (e.g.
0.5 mg kg-' i.v.) after 5-ALA sensitization could result in better
clinical PDT effects than with single 5-ALA application, without
considerable prolongation of skin photosensitivity.
MATERIAL AND METHODS
Cells, medium and chemicals
Undifferentiated colon adenocarcinoma cells (HT-29) were
maintained as a monolayer culture in Dulbecco's modified Eagle
medium (DMEM; Biochrom, Berlin, Germany), supplemented
with 10% fetal calf serum (FCS; Gibco, Eggenstein, Germany),
1% sodium pyruvate, 1% non-essential amino acids and penicillin/
streptomycin (100 IU ml-'/100 mg ml-') (all Gibco) at 37°C in a
5% carbon dioxide atmosphere. 5-ALA (Merck, Darmstadt,
Germany) and Photosan-3 (haematoporphyrin derivative; Seelab,
Wesselburenkoog, Germany) were dissolved in phosphate-
buffered saline (Biochrom) at a concentration of 1 mg ml-'.
Aliquots were diluted in DMEM toproduce in vitro concentrations
ranging from 0.1 to 100gg ml-', and these were used within 24 h.
Incubation of cells
When growing exponentially, cells were harvested by enzymatic
disaggregation with 0.5% trypsin-EDTA, washed with phosphate-
buffered saline (PBS), resuspended in DMEM and seeded out
in Falcon tubes. After 1 week, cells were incubated with 5-ALA
(5 and 50 jug ml-') for 18 or 24 h with or without HPD (0.5 and
5 gg ml-') simultaneously (24 h) or sequentially (6 h). After sensi-
tization, cells were washed in PBS, trypsinated and centrifuged at
1450 r.p.m. These cells were used for the determination of intra-
cellular PPIX concentration using high-performance thin-layer
chromatography (HPTLC). In another set of experiments, cells
were seeded out at a concentration of 15 000 cells per well in 96-
well dishes (Fa. Greiner, Frickenhausen, Germany) for PDT. After
a 24-h preincubation period, cells were first incubated simultane-
ously with 5-ALA (0, 1, 5, 10, 40, 60, 80 and 100 jg ml') and
HPD (0, 0.5, 2 and 5 jig ml-') for 24 h. Furthermore, cells were
incubated for 18 h with 5-ALA, washed in PBS, followed by
another incubation period of 6 h in sensitizer-free or HPD-
containing medium.
Spectrophotometric quantification of porphyrins by
thin-layer chromatography
Homogenization andesterification
The pelleted cell material was diluted with 1 ml of PBS, frozen
and thawed three times and sonicated for 20 s three times. This
extract was frozen in 20-ml tubes and freeze dried. The freeze-
dried material was esterified with methanol-sulphuric acid (95:5,
v/v) overnight.
Extraction oftheporphyrin methyl esters
The esterification mixture was extracted with chloroform after the
addition of about 5 ml of distilled water. The extraction of the
aqueous phase with chloroform was continued until the super-
natant no longer fluoresced under UV light (366 nm). The super-
natants were combined in a second extraction vessel, shaken
and neutralized with an aqueous sodium bicarbonate solution
(50 g l-1). The upper aqueous phase was withdrawn, and the chlo-
roform extracts were washed twice with about 4 ml of distilled
water. The aqueous phase must be neutral after the second
washing. Thechloroform extract was dried with 2-3 spatula tips of
dry sodium sulphate and filtered through a folded paper filter into
a flask. The flask was attached to a rotary evaporator, and the chlo-
roform was removed under vacuum at a temperature of25-30°C.
High-performance thin-layerchromatography
The dried porphyrin methyl esters were dissolved in a small
volume of chloroform (0.1-0.5 ml) and applied, in stripes, to the
silica gel with glass capillaries. The evaporation ofthe solvent was
Table 1 Intracellular porphyrin concentrations after sensitization with 5-ALA and/or HPD and corresponding CV
Sensitizer Uroporphyrin Coproporphyrin PPIX Total porphyrins CV(%)
(pmol ml-' cells) (pmol ml-' cells) (pmol ml-' cells) (pmol ml-' cells)
Control (no sensitizer) 0 0 0 0 100
5-ALA (24h; 5ug ml-') 0 0 85 85 93
5-ALA (24 h; 50 g ml-') 0 32 1313 1353 65
HPD (24 h; 5 g ml-') 0 89 72 161 11
5-ALA (24 h; 5 ug ml-') +HPD (24 h; 5 9g ml-') 0 68 85 153 36
5-ALA (24 h; 50 gg ml-') + HPD (24 h; 5 ig ml-') 0 59 220 279 34
5-ALA (18 h; 50 ug ml-') 23 65 1030 1118 78
5-ALA (18 h; 50 gg ml-') + medium (6 h) 23 32 476 531 88
HPD (6 h; 0.5 gg ml-') 0 32 40 72 90
HPD (6 h; 5 ug ml-') 0 63 36 99 21
5-ALA (18 h; 50 9g ml-') + HPD (6 h; 0.5 gg ml-') 0 0 553 553 63
5-ALA (18 h; 50 g ml-') +HPD (6 h; 5gg ml-') 0 64 178 242 18
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accelerated by a stream of air from a cold-air hair dryer placed
about 10 cm above the sheet.
The thin-layer sheets were placed in achromatography chamber
and a short prerun with chloroform methanol (120:20, v/v), 1 cm,
was performed. Then the chromatogram must be dried completely
for 40 min at room temperature in the dark, or 12 min under a
cold-air hair dryer. Chromatography in petroleum ether
(40-60'C)-diethyl ether (3:1, v/v) follows to the upper edge ofthe
sheet. Afterwards, the thin-layer sheets were run in benzene-ethyl
acetate-methanol (85:13.5:1.5 by volume), 8-14 cm.
Spectrophotometric analysis
In preparation for spectrophotometric analysis, the porphyrin
methyl esters were eluted from the thin-layer sheets. First, the red-
fluorescing zones were circled with a scalpel, scraped offthe plate,
transferred into a flask, eluted with a defined volume of chloro-
form and analysed spectrophotometrically between 650 and
350 nm. Calculation of the concentrations was done using the
millimolar extinction coefficient.
Irradiation procedure of HT-29 cells
At the end of the incubation period, the medium containing the
sensitizer was removed and replaced by PBS. The cells were
immediately photoirradiated using a PDT 1200 lamp (Waldmann
Medizintechnik, VS-Schwenningen, Germany) emitting inco-
herent light. The light source was a 1200-W metal halogen lamp
(MSR 1200; Philips, Eindhoven, The Netherlands); emission of
580-740 nm radiation was achieved by using dichroic cut-off
filters (DT Rot and Calflex-3000; Balzers Optik, Nuremberg,
Germany). Irradiation was performed using an output power of
40 mW cm-2. After photoirradiation, PBS was replaced with
culture medium and the dishes were incubated at 37°C for
another 48 h.
120-
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Figure 1 PDT of HT-29 colon carcinoma cells after simultaneous incubation
with 5-ALA and HPD at different drug doses for 24 h. Irradiation was
performed with 30 J cm-2 and an output power of 40 mW cm-2. Each point
represents the mean ± s.e. of three experiments. Cell viability was
determined as described in Material and methods
Assessment of cell viability
Mitochondrial activity as a parameter for cell viability was
determined using the MTT (3-[(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide]) assay (Mosman et al, 1983). After
the addition of 100,l of a 0.05% MTT solution (Sigma,
Deisenhofen, Germany) to each well, the dishes were incubated
for4 h at 37°C. Aliquots (100gl) of20% sodium dodecyl sulphate
(SDS) were added to each well in order to dissolve the MTT crys-
tals. After a 20-h incubation period at 37°C, optical density was
measured on an enzyme-linked immunosorbent assay (ELISA)
plate reader (Molecular Devices, USA) at 540 nm to assess cell
viability. Optical density as a measure of cell viability (CV) was
compared with that of the unirradiated control group without
sensitizer application, which was set to 100%.
Statistical analysis
Each individual experiment was repeated at least three times. Data
are presented as the means of at least nine measurements with
standard errors. Differences were tested for statistical significance
with the one-way repeated measures ANOVA or the one-way
ANOVA on ranks. Statistically significant differences were
assumed at P < 0.05.
RESULTS
Intracellular porphyrin concentrations after
sensitization with 5-ALA and HPD
The intracellular porphyrin concentrations ofuroporphyrin, copro-
porphyrin and PPIX, as well as the total porphyrin concentrations,
are shown in Table 1. Highest PPIX concentrations were achieved
after single incubation with 5-ALA, depending on incubation time
and 5-ALA dose. Single incubation with HPD was followed by
lower PPIX concentrations compared with 5-ALA sensitization,
but relatively high values ofcoproporphyrins.
PPIX concentrations were identical after simultaneous incuba-
tion with 5-ALA and HPD (5,g ml-' each) for 24 h or single 5-
ALA (5 ,g ml-') incubation, which resulted in 85 pmol ml-1 cells,
but were significantly higherwith 50 jg ml-' 5-ALA and 5 jig ml-'
HPD (220 pmol ml-' cells; P < 0.01). However, while 24 h incuba-
tion with 50 jg ml-' 5-ALA yielded 1313 pmol ml-' cells ofPPIX,
5, g ml-' HPD induced only 72 pmol ml-' cells ofPPIX. Thus, the
combined incubation resulted not in an additional effect of the
PPIX concentration but in a significantly reduced PPIX value of
220 pmol ml-' cells.
A sequential incubation of 5-ALA and HPD also showed lower
PPIX concentrations compared with single 5-ALA sensitization.
However, the higher the HPD concentration, the lower the PPIX
concentrations.
PDT effect on HT-29 cells after sensitization with either
5-ALA or HPD alone
Incubation of HT-29 cells with 0.5 jig ml-' HPD alone for 24 h
yielded a CV of 70%, whereas 5 jig ml-' HPD yielded a CV of
only 11% (P < 0.001) (Figure 1). PDT ofHT-29 cells after 5-ALA
sensitization alone resulted in an almost linear decrease of CV
with increasing 5-ALA doses (Figure 1). Comparing the dose
of both sensitizers, HPD was more effective than 5-ALA, since
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Figure 2 PDT of HT-29 colon carcinoma cells after sequential incubation
with 5-ALA for 18 h and HPD for 6 h. Irradiation was performed with
30 J cm-2 and an output power of 40 mW cm-2. The vertical lines to the x-axis
indicate different 5-ALA concentrations in combination with HPD to reduce
CV by 40%. Each point represents the mean ± s.e. of three experiments. Cell
viability was determined as described in Material and methods
2 jg ml-' HPD induced the same cytotoxic effect of 60% CV as
50 jg ml' 5-ALA (Figure 1).
PDT effect on HT-29 cells after simultaneous
sensitization with 5-ALA and HPD
Simultaneous incubation ofHPD and 5-ALA turned out to be less
cytotoxic than exclusive sensitization with HPD. HPD alone
(5 jg ml-') reduced CV to 11% after irradiation, while its combi-
nation with 1 jig ml-' 5-ALA decreased cytotoxicity by 20%.
Similareffects could be demonstrated foreach ofthe HPD concen-
trations combined with 5-ALA (Figure 1).
Moreover, increasing the concentration of 5-ALA without
changing the dose of HPD was not followed by a better PDT
effect. The lowest concentration of 5-ALA (1 jg ml-') used in
combination with 5 jg ml-' HPD had the samecell-killing efficacy
as 50 jg ml-' 5-ALA together with 5 jig ml' HPD, resulting in a
CV of 35% or 34% respectively. Accordingly, the CV after simul-
taneous incubation with 5-ALA and HPD appeared to be indepen-
dent of 5-ALA concentrations, but was mostly determined by
HPD. For example, the combination of 50 jig ml-' 5-ALA with
5 jig ml-' HPD induced a more than 40% higher cell cytotoxicity
compared with a tenfold lower dose of HPD in this combination
with 5-ALA (Figure 1).
Comparing the PDT effect on cell viability after sensitization
with low doses of 5-ALA (1-40 jig ml-') alone or in combination
with HPD, the combined administration of both sensitizers seems
to be superior to the isolated use of 5-ALA. This effect was
independent of the 5-ALA concentration and therefore was only
influenced by the more powerful sensitizer HPD.
In contrast, higher doses of 5-ALA alone (. 80 jig ml-') were
more toxic than their combination with 0.5 or 2 jig ml-' HPD.
Accordingly, PDT with 100 jig ml-' 5-ALA reduced the CV to 3%,
whereas its combination with 0.5 jig ml-' HPD reduced cytotoxi-
city by almost 71% (Figure 1).
PDT effect on HT-29 cell viability after successive
exposure to 5-ALA and HPD
Simultaneous incubation of 5-ALA and HPD indicated that both
sensitizers can interfere with each other, thus reducing the PDT
effect compared with single incubation with either HPD or 5-ALA
(> 80 jg ml-'). Therefore, the incubation period of 24 h was split
into 18 h with 5-ALA followed by 6 h with HPD to ensure that
cells were photoradiated after the same total incubation time.
Incubation with 5-ALA (18 h) followedby a 6-hperiod in sensi-
tizer-free medium showed no difference in CV when compared
with unsensitized control cells (no 5-ALA) (Figure 2). However,
5-ALA (18 h) followed by HPD (6 h) reduced the CV after irradi-
ation compared with either drug alone. Single incubation with
2 gg ml-' HPD reduced the CV to 60%, and exclusive sensitization
with 100 jg ml-' 5-ALA resulted in a CV of 47%, whereas
sequential administration ofboth compounds yielded a 29% CV of
HT-29 cells.
The 5-ALA dose (LD40) needed to induce a lethality of40% can
be lowered to 57 jig ml- and 5 jg ml-' 5-ALA, when sequentially
combined with 0.5 and 2 jig ml-1 ofHPD respectively (Figure 2).
Correlation of intracellular porphyrins and CV
After single incubation with 5-ALA, the CV correlated well with
PPIX concentration (r = 0.97). However, in combination with
HPD, the co-relationship for PPIX and CV decreased to 0.15, while
the coproporphyrin concentration correlated better (r = 0.74).
DISCUSSION
The clinical and pharmacological use of combination
chemotherapy has been widely studied in animal models (Dexter
et al, 1986). The combination of antineoplastic drugs has several
advantages over single drug treatment: (1) increasing therapeutic
synergism by exploiting different mechanisms of action; (2)
increasing patient tolerance by minimizing side-effects of drugs
owing to lower doses of each individual compound; and (3)
preventing or delaying the emergence ofresistant cell clones.
In vitro and in vivo studies have indicated enhanced tumour
cytotoxicity when PDT was combined with hyperthermia (Kinsey
et al, 1983; Waldow et al, 1985) or chemotherapy (Creekmore
et al, 1983; Jin et al, 1992). Combination of different sensitizers
is another approach to increasing the PDT effect. By combining
haematoporphyrins (2.5 mg kg-') with meso-tetra-(4-sulphonato-
phenyl)-porphine (TPPS4; 2.5 mg kg-') and irradiation at the
appropriate wavelength for each sensitizer, enhanced tumour
eradication compared with either sensitizer alone (5 mg kg-') was
achieved (Nelson et al, 1990).
5-ALA sensitization seems to represent an attractive approach
to improve PDT by reducing skin photosensitivity and increasing
tumour selectivity (Regula et al, 1995). However, its use in cancer
treatment is limited by only superficial tumour necrosis (Regula et
al, 1995). This problem prompted us to evaluate the PDT effect of
a combination of 5-ALA with a second photosensitizer, HPD.
5-ALA is converted intracellularly to PPIX and other
porphyrins, which represent the actual phototoxic agents inducing
direct tumour cell necrosis. PDT after HPD pretreatment destroys
the tumour both directly, and mainly indirectly, by targeting
the microvasculature of neoplastic tissue (Nelson et al, 1988;
Leunig et al, 1994).
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A combination of a compound with fewer side-effects and
another compound with high anti-tumour cytotoxicity might have
an additive or synergistic effect with respect to drug tolerance or
therapeutic efficacy. Therefore, this combination appears to be
particularly interesting underin vivo conditions, since theirdifferent
mechanisms ofaction could result in therapeutic synergism.
Our findings on PPIX determination using HPTLC indicated
that single incubation with 5-ALA resulted in significantly higher
PPIX values and correlated well with CV (r = 0.97). However,
sensitization with HPD alone or in combination with 5-ALA either
simultaneously or sequentially led to decreased PPIX concentra-
tions. The coproporphyrin concentrations were significant lower
than PPIX, but correlated well with CV (r = 0.74) while the PPIX
concentrations did not show any correlation with CV ifboth sensi-
tizers were combined (r = 0.15). Therefore, the presence of HPD
influenced PPIX synthesis negatively. This hypothesis is further
confirmed by the observation that, after 18 h incubation with
50,g ml-' 5-ALA followed by 6 h HPD sensitization, PPIX
decreased in the presence of a higher HPD drug dose. However,
from these data, it is not clear which are the photoactive
compounds ofHPD; therefore, we cannot conclude that copropor-
phyrin is the major photoactive agent, since HPD consists of
several other porphyrin compounds not measurable by HPTLC.
In contrast, tumour cell cytotoxicity after HPD alone was much
more pronounced compared with the simultaneous combination of
HPD and 5-ALA also PPIX concentrations were lower (Figure 1).
One explanation for this unexpected finding could be that, after 5-
ALA administration, endogenously produced porphyrins interfere
with HPD, perhaps by replacing HPD with less-photosensitizing
porphyrins. Furthermore, coproporphyrin concentrations were
increased after single HPD.
Increasing the dose of 5-ALA while the concentration of HPD
was kept constant did not change the CV ofHT-29. In the presence
of HPD, the intracellular conversion of 5-ALA to PPIX might be
disturbed.
In summary, our findings indicated that simultaneous incubation
of HPD and the prodrug 5-ALA interferes with each other, and
therefore single incubation with HPD or with higher doses of 5-
ALA was superior. One way to overcome this unfavourable inter-
action counteracting tumour cell cytotoxicity could be sequential
administration of both compounds. 5-ALA followed by HPD
could allow PPIX to be synthesized from the prodrug in the
absence ofany interference by exogenously added products ofthe
pathway (Figure 2). Tumour cell cytotoxicity after sequential
incubation ofhuman colon carcinoma cells with 5-ALA and HPD
affected tumour cell viability much more than either compound
alone. If after an 18-h incubation period with 5-ALA, cells were
cultured in sensitizer-free medium for another 6 h, the PDT effect
was not different from that of control cells (no 5-ALA), and
porphyrin concentrations retumed to control levels 6 h after 5-
ALA had been eliminated from the incubation medium. This
phenomenon has been demonstrated by Steinbach et al (1995),
who described an efflux ofPPIX into the supernatant ofcells.
Taken together, single incubation with 5-ALA correlated well
with PPIX synthesis and CV, while a combination with HPD
resulted in lower PPIX concentrations. Also, PPIX concentrations
were not significantly different for simultaneous and sequential
incubation with HPD, the best PDT effect could be found for
sequential incubation with HPD and 5-ALA. From these data, we
conclude that HPD influences PPIX synthesis, and the PDT effect
depends mostly on HPD and to a lesser extent on 5-ALA.
These experiments indicated that the PDT effect can be
enhanced by combining a sensitizing prodrug (5-ALA) with HPD
under certain circumstances, depending on the sequence of sensi-
tizer administration and on the incubation time. In PDT, the
enhanced anti-tumour effect of 5-ALA when followed by the
administration of HPD warrants further in vivo studies to clarify
whether the combination ofboth sensitizers in sequence is associ-
ated with fewer side-effects but high anti-tumour activity.
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